SCHEMBL2072500

SCHEMBL2072500

CCOC(=O)Nc1ccc(N)cc1C(F)(F)F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.54
CYP2C9 P11712 2/20 0.54
CYP2C19 P33261 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.52
KCNQ2 O43526 8/20 0.50
KCNQ3 O43525 6/20 0.50
KCNQ4 P56696 3/20 0.47
KCNQ5 Q9NR82 3/20 0.47
HDAC3 O15379 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC2 Q92769 1/20 0.45
ABCB11 O95342 1/20 0.44
ESR1 P03372 1/20 0.44
CYP3A4 P08684 1/20 0.44
HTR1A P08908 1/20 0.44
ADRA2A P08913 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CYP2D6 P10635 1/20 0.44
ALOX15 P16050 1/20 0.44
NFKB1 P19838 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2070063 0.89 KMT2A (0.49) CYP1A2CYP2C9CYP2C19SMN1; SMN2KCNQ2
SCHEMBL17665517 0.87 HPGD (0.47) CYP1A2CYP2C9CYP2C19SMN1; SMN2HDAC3
SCHEMBL6333634 0.83 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19SMN1; SMN2KCNQ2
SCHEMBL17653871 0.82 NPC1 (0.51) SMN1; SMN2HDAC3HDAC1HDAC2KMT2A
SCHEMBL2069644 0.81 SMN1; SMN2 (0.73) CYP1A2CYP2C9CYP2C19SMN1; SMN2KCNQ2
SCHEMBL11451154 0.81 CYP1A2 (0.61) CYP1A2CYP2C9CYP2C19SMN1; SMN2KCNQ2
SCHEMBL4957900 0.81 POLB (0.48) CYP1A2CYP2C9CYP2C19SMN1; SMN2CYP2D6
SCHEMBL656064 0.80 CYP1A2 (0.59) CYP1A2CYP2C9CYP2C19SMN1; SMN2KCNQ2
SCHEMBL2072406 0.80 CYP1A2 (0.59) CYP1A2CYP2C9CYP2C19SMN1; SMN2KCNQ2
SCHEMBL21059165 0.80 KMT2A (0.59) CYP1A2CYP2C9CYP2C19CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7906537-B2 Substituted p-diaminobenzene derivatives H. LUNDBECK A/S (DK) 2011-03-15 US disclosed
US-20060183791-A1 Substituted p-diaminobenzene derivatives H. LUNDBECK A/S (DK) 2006-08-17 US disclosed
EP-1613303-A1 SUBSTITUTED P-DIAMINOBENZENE DERIVATIVES H. Lundbeck A/S (DK) 2006-01-11 EP disclosed
WO-2004082677-A1 SUBSTITUTED P-DIAMINOBENZENE DERIVATIVES H. LUNDBECK A/S (DK) 2004-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060183791-A1 Substituted p-diaminobenzene derivatives ABCB1, UGT2B7, CYP2D6 CYP1A2 20/4885CYP2C9 25/4885CYP2C19 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.